These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 19616501)

  • 1. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.
    Lu Y; Mekoo DJ; Ouyang K; Hu X; Liu Y; Lin M; Jin L; Cao R; Li T; Zhang Y; Fan H; Liu J
    Endocr Relat Cancer; 2009 Dec; 16(4):1171-84. PubMed ID: 19648182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a potent DNA vaccine targeting B-cell epitopes of hGRP induces prophylactic and therapeutic antitumor activity in vivo.
    Yong L; Huiyong Z; Jing H; Huaqian W; Xiangbing H; Yanjun M; Xiaoyu G; Li H; Yanan Y; Rongyue C; Hao F; Jingjing L; Jie W
    Gene Ther; 2010 Apr; 17(4):459-68. PubMed ID: 20130655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
    Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
    Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
    Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.
    Xu HB; Xu W; Chu YW; Wang Y; Xiong S
    Immunol Lett; 2005 Jul; 99(2):186-92. PubMed ID: 16009269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunol Lett; 2005 Jun; 99(1):85-93. PubMed ID: 15894116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.
    Xu J; Zhu Z; Wu J; Liu W; Shen X; Zhang Y; Hu Z; Zhu D; Roque RS; Liu J
    Cancer Lett; 2008 Feb; 259(2):240-50. PubMed ID: 18039558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific antibodies elicited by a novel DNA vaccine targeting gastrin-releasing peptide inhibit murine melanoma growth in vivo.
    Fang J; Lu Y; Ouyang K; Wu G; Zhang H; Liu Y; Chen Y; Lin M; Wang H; Jin L; Cao R; Roque RS; Zong L; Liu J; Li T
    Clin Vaccine Immunol; 2009 Jul; 16(7):1033-9. PubMed ID: 19458203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
    Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yankai Z; Rong Y; Yi H; Wentao L; Rongyue C; Ming Y; Taiming L; Jingjing L; Jie W
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1365-71. PubMed ID: 16725110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cells.
    Pudney VA; Metheringham RL; Gunn B; Spendlove I; Ramage JM; Durrant LG
    Eur J Immunol; 2010 Mar; 40(3):899-910. PubMed ID: 20039301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M
    Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.